Home » MYOGEN TO SEEK APPROVAL FOR AMBRISENTAN
MYOGEN TO SEEK APPROVAL FOR AMBRISENTAN
Biopharmaceutical company Myogen Inc. said Monday it plans to file a new drug application for its blood pressure treatment ambrisentan after positive results from a late-stage clinical trial.
The
Houston Chronicle
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May